Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 361
interventional 248
Observational 105
Registry 8

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 89
Procedure 30
Drug|placebo 27
Drug|Procedure 25
Device 17
Behavioral 14
Other 14
Drug|Other 9
Device|Drug 4
Diagnostic Test 4
Dietary Supplement 3
Device|Drug|Other 2
Device|Other 2
Behavioral|Drug|Procedure 1
Behavioral|Other 1
Biological 1
Device|Drug|Procedure 1
Device|Procedure 1
Genetic 1
Other|placebo 1
Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 81
NA 24
Mexico 16
China 15
Brazil 12
France 8
Denmark 6
Korea, Republic of 6
Austria 5
United Kingdom 5
Canada 4
Italy 4
Taiwan 4
United States|Canada 4
Australia 3
Egypt 3
Germany 3
Portugal 3
India 2
Iran, Islamic Republic of 2
Japan 2
Nepal 2
Spain 2
Thailand 2
Australia|Brazil|Hungary|Italy|Netherlands|Poland|South Africa|Spain|United Kingdom 1
Australia|Denmark 1
Australia|Denmark|Germany|Italy|Netherlands 1
Australia|New Zealand 1
Bangladesh 1
Belgium|Czechia|Denmark|Germany|Greece|Italy|Macedonia, The Former Yugoslav Republic of|Netherlands|Spain|United Kingdom 1
Belgium|France|Germany|Slovakia|Spain|Switzerland|United Kingdom 1
Chile 1
Croatia 1
Czechia|Hungary|Slovakia 1
Denmark|France|Germany|Italy|Portugal|Spain|United Kingdom 1
Finland|Spain|Sweden|United Kingdom 1
France|Italy|Portugal|United Kingdom 1
Hong Kong 1
Indonesia 1
Ireland 1
Lebanon 1
Malaysia 1
Romania 1
Saudi Arabia 1
Switzerland 1
Syrian Arab Republic 1
United States|Australia|Belgium|Czech Republic|France|Germany|Israel|Italy|Poland|Spain 1
United States|Australia|Brazil|Canada|Denmark|France|Germany|India|Italy|Mexico|Netherlands|Poland|Portugal|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Austria|Greece|Italy|Norway|Portugal|Spain|United Kingdom 1
United States|Belgium|Czech Republic|Germany|Israel|Poland|United Kingdom 1
United States|Canada|Mexico 1
United States|Czechia|France|Germany|Hungary|Israel|Italy|Spain|United Kingdom 1
United States|Germany|Hungary|Japan|Puerto Rico|United Kingdom 1
United States|Puerto Rico|Slovakia|Spain|United Kingdom 1

Sites per Study

Site_count Study_Count
1 177
2 17
3 8
4 4
5 1
7 6
8 1
11 1
12 2
13 2
15 2
16 3
18 1
23 1
29 1
30 1
34 2
37 2
38 1
39 1
45 1
48 1
50 1
51 1
53 1
56 1
58 1
62 1
65 1
67 1
73 1
84 1
85 1
89 1

Phase

Phase Study_Count
N/A 86
Phase 2 49
Phase 3 42
Phase 4 29
Phase 1 20
Phase 1/Phase 2 9
Phase 2/Phase 3 9
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 44
2 135
3 28
4 10
5 1
6 1
8 1
9 1
NA 27

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 16.0 8.000 4.00 5.00000 6.00000 20.000 5.0000 7.0000
1st Qu. 41.5 40.000 10.00 16.00000 29.50000 30.000 71.0000 23.7500
Median 75.0 110.000 17.50 30.00000 54.00000 149.500 305.0000 45.0000
Mean 191.5 1259.547 35.50 30.77778 80.64583 358.375 729.4054 122.8929
3rd Qu. 225.0 368.000 44.25 48.00000 105.50000 308.250 691.0000 84.0000
Max. 600.0 60000.000 165.00 60.00000 315.00000 1777.000 5238.0000 1060.0000

Trial Group Type

group_type Group_Count
Experimental 243
Active Comparator 114
Placebo Comparator 50
NA 27
No Intervention 24
Other 24
Sham Comparator 11

Intervention Model

intervention_model Study_Count
Parallel Assignment 159
Single Group Assignment 59
NA 11
Crossover Assignment 10
Sequential Assignment 6
Factorial Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 175
Prevention 20
Diagnostic 13
Health Services Research 9
Screening 9
Other 7
Supportive Care 5
NA 5
Basic Science 4
Device Feasibility 1

Observational Studies

Studies by Country

Country Study_Count
United States 38
NA 12
Portugal 9
China 7
Taiwan 6
France 4
Brazil 3
Mexico 3
United Kingdom 3
Canada 2
Denmark 2
Italy 2
Japan 2
Austria 1
Belgium 1
Bolivia 1
Germany 1
India 1
India|Portugal 1
Israel 1
Korea, Republic of 1
Singapore 1
Spain 1
Sweden 1
Switzerland 1

Sites per Study

Site_count Study_Count
1 92
2 5
3 5
7 1
32 1
48 1

Enrollment Metrics

Measure Observational
Min 7.0000
1st Qu 52.0000
Median 132.0000
Mean 663.5714
3rd Qu 374.0000
Max 19199.0000

Observation Model

observational_model Study_Count
Cohort 32
Case-Only 20
Case-Control 18
Case Control 11
NA 10
Other 9
Ecologic or Community 3
Case-Crossover 2

Time Perspective

time_perspective Study_Count
Prospective 64
Cross-Sectional 17
Retrospective 12
NA 7
Other 5

Registries

Studies by Country

Country Study_Count
China 2
Denmark 1
France 1
Mexico 1
NA 1
Portugal 1
United States 1

Sites per Study

Site_count Study_Count
1 6
2 1
3 1

Enrollment Metrics

Measure Registries
Min 30.0
1st Qu 73.5
Median 172.0
Mean 63001.5
3rd Qu 1375.0
Max 500000.0

Registry Model

observational_model Study_Count
Cohort 7
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 8

Follow-up

target_duration Study_Count
1 Day 1
10 Years 1
12 Months 1
16 Years 1
20 Years 1
3 Years 1
4 Years 1
5 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT03343730 RetinaVue Diabetic Screening https://ClinicalTrials.gov/show/NCT03343730 Recruiting Bassett Healthcare 2018-10-01
NCT03278587 Village-Integrated Eye Worker Trial II - Pilot https://ClinicalTrials.gov/show/NCT03278587 Recruiting Francis I. Proctor Foundation 2020-08-31
NCT03242031 Medico-economic Comparison Between Treatment With Panretinal Photocoagulation by Laser in 1 Session Versus 4 Sessions in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03242031 Recruiting Centre Hospitalier Universitaire Dijon 2021-03-31
NCT03238963 A Study That Tests BI 1467335 in Patients With Diabetic Eye Disease (Diabetic Retinopathy). It Looks at the Way BI 1467335 is Taken up, the Effects it Has, and How Well it is Tolerated. https://ClinicalTrials.gov/show/NCT03238963 Completed Boehringer Ingelheim 2020-02-14
NCT03197870 The TIME-2b Study: A Study of AKB-9778, a Novel Tie 2 Activator, in Patients With Non-Proliferative Diabetic Retinopathy (NPDR) https://ClinicalTrials.gov/show/NCT03197870 Completed Aerpio Therapeutics 2019-01-09
NCT03161652 Effect of Levosulpiride on Retinal Alterations in Patients With Diabetic Retinopathy and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03161652 Recruiting Universidad Nacional Autonoma de Mexico 2022-05-31
NCT03150654 The Effect of Laser Treatment on Macular Pigment of Eye in Cases With Diabetes https://ClinicalTrials.gov/show/NCT03150654 Completed Afyon Kocatepe University Hospital 2016-06-08
NCT03113006 The Individually-Marked Panretinal Laser phoTocoagulation for Proliferative Diabetic Retinopathy Study (TREAT) https://ClinicalTrials.gov/show/NCT03113006 Completed Odense University Hospital 2019-08-27
NCT03094819 PROTECT2: Diabetes Care - Eye Exam https://ClinicalTrials.gov/show/NCT03094819 Active, not recruiting Retinal Care Inc. 2021-06-30
NCT03071068 A Study to Evaluate the Safety and Efficacy of THR-317 for the Treatment of Diabetic Macular Oedema (DME) https://ClinicalTrials.gov/show/NCT03071068 Completed ThromboGenics 2018-04-30
NCT02995629 Patient Comfort Using Green vs. Yellow Pan Retinal Photocoagulation https://ClinicalTrials.gov/show/NCT02995629 Completed Wills Eye 2016-10-31
NCT02911311 Conbercept vs Panretinal Photocoagulation for the Management of Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02911311 Enrolling by invitation Sun Yat-sen University 2019-12-31
NCT02879422 Genetic Markers and Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02879422 Recruiting CHU de Reims 2020-04-16
NCT02874313 CPAP Effect on the Progression of Diabetic Retinopathy in Patients With Sleep Apnea https://ClinicalTrials.gov/show/NCT02874313 Active, not recruiting Hospital Universitario La Paz 2020-10-31
NCT02866734 Diabetic Retinopathy Screening in Private Practice https://ClinicalTrials.gov/show/NCT02866734 Completed The University of Hong Kong 2017-12-13
NCT02863354 Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02863354 Active, not recruiting Greater Houston Retina Research 2019-07-31
NCT02858076 Anti-VEGF vs. Prompt Vitrectomy for VH From PDR https://ClinicalTrials.gov/show/NCT02858076 Completed Jaeb Center for Health Research 2020-01-31
NCT02857491 Intravitreal Injection of Ranibizumab Versus Sham Before Vitrectomy in Patients With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02857491 Completed Sun Yat-sen University 2017-09-30
NCT02834663 Effects of Intravitreal Ranibizumab for Macular Edema With Nonproliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02834663 Completed Wonkwang University Hospital 2019-02-28
NCT02826655 Adaptive Optics for Ophthalmic Technologies https://ClinicalTrials.gov/show/NCT02826655 Recruiting Duke University 2021-06-30
NCT02823600 Feasibility Study of Retinal Screening Using the RetinaVue 100 Camera in Outpatient Dialysis Centers https://ClinicalTrials.gov/show/NCT02823600 Completed University of North Carolina, Chapel Hill 2017-05-31
NCT02816710 Conbercept Injection in Treatment of Severe Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02816710 Completed Ruijin Hospital 2017-09-30
NCT02816073 Pattern Scanning Laser Pan-retinal Photocoagulation in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02816073 Completed United Christian Hospital 2013-11-30
NCT02806830 Ocular Discomfort Assessment After Intravitreal Injections https://ClinicalTrials.gov/show/NCT02806830 Completed Centre Hospitalier Intercommunal Creteil 2017-01-31
NCT02753400 Study to Evaluate Effects of Emixustat Hydrochloride in Subjects With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02753400 Completed Kubota Vision Inc. 2017-11-30
NCT02718326 Study of the Efficacy and Safety of Intravitreal (IVT) Aflibercept for the Improvement of Moderately Severe to Severe Nonproliferative Diabetic Retinopathy (NPDR) https://ClinicalTrials.gov/show/NCT02718326 Completed Regeneron Pharmaceuticals 2018-08-06
NCT02706977 The Effect of Dopamine on Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02706977 Completed Emory University 2019-08-15
NCT04424290 HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia https://ClinicalTrials.gov/show/NCT04424290 Recruiting Boehringer Ingelheim 2022-05-18
NCT02705274 PRP vs Bevacizumab for PDR Treatment https://ClinicalTrials.gov/show/NCT02705274 Completed Marashi Eye Clinic 2017-04-30
NCT02691429 Applicability of the Acai Fruit (Euterpe Oleracea) Dye for Chromovitrectomy in Humans https://ClinicalTrials.gov/show/NCT02691429 Completed Federal University of São Paulo 2016-11-30
NCT02681809 A Study to Evaluate the Efficacy and Safety of Ocriplasmin in Inducing Total PVD in Subjects With NPDR https://ClinicalTrials.gov/show/NCT02681809 Completed Oxurion 2019-11-18
NCT02647515 Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma https://ClinicalTrials.gov/show/NCT02647515 Completed Ruijin Hospital 2014-12-31
NCT02645383 PASCAL Laser Platform Produces Less Pain Responses Compared To Conventional Laser System https://ClinicalTrials.gov/show/NCT02645383 Completed Kocatepe University 2014-07-31
NCT02634333 Anti-VEGF Treatment for Prevention of PDR/DME https://ClinicalTrials.gov/show/NCT02634333 Active, not recruiting Jaeb Center for Health Research 2020-05-31
NCT02621580 Investigating the Structural and Functional Changes to the Retina Following PRP in Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT02621580 Completed Lawson Health Research Institute 2017-08-31
NCT02590094 Comparison of Interval Variation and Dosage in Preoperative Bevacizumab and Ziv-Aflibercept Administration in Proliferative Diabetic Retinopathy Undergoing Vitrectomy https://ClinicalTrials.gov/show/NCT02590094 Recruiting Panhandle Eye Group, LLP 2021-10-31
NCT02587741 Comparison of Diabetes Retinopathy Among Type 2 Diabetic Patients Treated With Different Regimens https://ClinicalTrials.gov/show/NCT02587741 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2023-07-31
NCT04120077 Combined Effects of Diabetes Self-Management Education and Nutritional Supplementation on Visual Function and Retinopathy https://ClinicalTrials.gov/show/NCT04120077 Recruiting ZeaVision, LLC 2020-11-01
NCT04117022 Diabetic Retinopathy Functional Evaluation Study: Monitoring Carotenoid Vitamins Treatment Using ERG https://ClinicalTrials.gov/show/NCT04117022 Recruiting ZeaVision, LLC 2020-12-01
NCT02559180 Treatment of Diabetic Macular Edema With Aflibercept in Subjects Previously Treated With Ranibizumab or Bevacizumab https://ClinicalTrials.gov/show/NCT02559180 Recruiting The Cleveland Clinic 2020-11-30
NCT02521116 Comparison of Retinal Oxygenation and Retinal Vessel Diameters in Healthy Subjects and Patients With Diabetic Retinopathy or Retinal Vein Occlusion Between DVA and Oxymap https://ClinicalTrials.gov/show/NCT02521116 Completed Medical University of Vienna 2017-01-03
NCT02510885 SD-OCT Angiography https://ClinicalTrials.gov/show/NCT02510885 Recruiting Duke University 2020-05-31
NCT02475109 Study of Topical Ocular PAN-90806 in PDR https://ClinicalTrials.gov/show/NCT02475109 Completed PanOptica, Inc. 2016-05-31
NCT02457975 Photobiomodulation for the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02457975 Completed Medical College of Wisconsin 2019-08-30
NCT02447185 25-G Vitrectomy With Ranibizumab or Triamcinolone Acetonide on PDR in China-Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT02447185 Recruiting The First People’s Hospital of Xuzhou 2020-12-31
NCT02435862 A Clinical Trial Designed to Evaluate the Safety and Efficacy Study of Luminate® in Inducing PVD (Posterior Vitreous Detachment) in Non-Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02435862 Completed Allegro Ophthalmics, LLC 2017-08-10
NCT02432547 Laser Therapy Combined With Intravitreal Aflibercept vs Intravitreal Aflibercept Monotherapy (LADAMO) https://ClinicalTrials.gov/show/NCT02432547 Active, not recruiting University of Sydney 2021-01-31
NCT02390245 Philadelphia Telemedicine Glaucoma Detection and Follow-Up Study https://ClinicalTrials.gov/show/NCT02390245 Active, not recruiting Wills Eye 2019-09-30
NCT02366468 Study of Efficacy of Ranibizumab in Different Regimens in Patients With Diabetic Macula Edema https://ClinicalTrials.gov/show/NCT02366468 Completed Novartis 2017-06-08
NCT02339909 Incentives in Diabetic Eye Assessment by Screening https://ClinicalTrials.gov/show/NCT02339909 Completed Imperial College London 2015-12-31
NCT02307110 Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy https://ClinicalTrials.gov/show/NCT02307110 Completed Vista Klinik 2014-12-31
NCT02261194 Effect of a Self-care Intervention on Depression in People With Age-related Macular Degeneration or Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02261194 Completed Maisonneuve-Rosemont Hospital 2016-02-29
NCT02249897 PRELIMINARY EVALUATION OF PHARMACOLOGICAL LOWERING OF AGEs https://ClinicalTrials.gov/show/NCT02249897 Completed University of Chile 2017-12-31
NCT02207712 Noctura400 Treatment for Diabetic Retinopathy (CANDLE) https://ClinicalTrials.gov/show/NCT02207712 Active, not recruiting PolyPhotonix Medical 2020-07-31
NCT02177747 Smartphone-based Ophthalmoscopy https://ClinicalTrials.gov/show/NCT02177747 Completed Università degli Studi di Brescia 2014-04-30
NCT02157350 The Individually Marked Panretinal lasEr phoTokoagUlation for Proliferative Diabetic Retinopathy Study - DETECT https://ClinicalTrials.gov/show/NCT02157350 Completed Odense University Hospital 2017-09-30
NCT02151695 Safety and Efficacy of Aflibercept in Proliferative Diabetic Retinopathy. https://ClinicalTrials.gov/show/NCT02151695 Completed Poitiers University Hospital 2018-10-31
NCT02121340 Collaborative Care for Depression and Diabetic Retinopathy in African Americans https://ClinicalTrials.gov/show/NCT02121340 Completed Thomas Jefferson University 2018-12-31
NCT02099981 Restoration of Retinal Vascular Responses in Type 1 Diabetic Patients https://ClinicalTrials.gov/show/NCT02099981 Completed University of Minnesota 2017-12-31
NCT02085681 Study of Effectiveness of Telemedicine in Identifying Diabetic Retinopathy Cases https://ClinicalTrials.gov/show/NCT02085681 Completed Aravind Eye Care System 2015-01-31
NCT02062034 Efficacy of Ubiquinone and Combined Antioxidant Therapy in Non-proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02062034 Completed University of Guadalajara 2013-11-30
NCT01298076 Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01298076 Completed University of Sydney 2014-09-30
NCT01295775 Diabetic Retinopathy Sulodexide Study https://ClinicalTrials.gov/show/NCT01295775 Completed Ajou University School of Medicine 2011-04-30
NCT01281098 Prospective, Randomized, Open Label, Phase II Study to Assess Efficacy and Safety of Macugen® (Pegaptanib 0.3 mg Intravitreal Injections) Plus Panretinal Photocoagulation and PRP (Monotherapy) in the Treatment With High Risk PDR. https://ClinicalTrials.gov/show/NCT01281098 Completed Association for Innovation and Biomedical Research on Light and Image 2012-10-31
NCT01280929 Prospective, Randomized, Multicenter, Open Label, Phase II Study to Access Efficacy and Safety of Lucentis® Monotherapy Compared With Lucentis® Plus Panretinal Photocoagulation (PRP) and PRP in the Treatment of Patients With High Risk Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01280929 Completed Association for Innovation and Biomedical Research on Light and Image 2013-12-31
NCT01270542 Avastin for PDR (Proliferative Diabetic Retinopathy) https://ClinicalTrials.gov/show/NCT01270542 Completed University of Southern California 2011-07-31
NCT02040441 Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria https://ClinicalTrials.gov/show/NCT02040441 Completed Steno Diabetes Center Copenhagen 2018-11-30
NCT01988246 Prevention of Macular Edema In Patients With Diabetic Retinopathy Undergoing Cataract Surgery https://ClinicalTrials.gov/show/NCT01988246 Completed The Cleveland Clinic 2018-04-25
NCT01976923 Pre-Operative Intravitreal Bevacizumab for Tractional Retinal Detachment Secondary to Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01976923 Completed King Khaled Eye Specialist Hospital 2018-07-31
NCT01950663 RETeval Study for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01950663 Completed Inoveon Corporation 2014-04-30
NCT01941329 Prospective, Randomized, Multicentre, Open-label, Phase II / III Study to Assess Efficacy and Safety of Ranibizumab 0.5 mg Intravitreal Injections Plus Panretinal Photocoagulation (PRP) Versus PRP in Monotherapy in the Treatment of Subjects With High Risk Proliferative Diabetic Retinopathy. https://ClinicalTrials.gov/show/NCT01941329 Completed Association for Innovation and Biomedical Research on Light and Image 2016-04-30
NCT01927315 Effects of Fenofibrate on Endothelial Progenitor Cells in Diabetes https://ClinicalTrials.gov/show/NCT01927315 Completed University of Padova 2019-10-31
NCT01920984 Vitreous Levels of Cysteine-rich 61 in Patients With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01920984 Completed National Taiwan University Hospital 2006-12-31
NCT01908816 An Open-label Extended Clinical Protocol of Ranibizumab to Evaluate Safety and Efficacy in Rare VEGF Driven Ocular Diseases. https://ClinicalTrials.gov/show/NCT01908816 Completed Novartis 2016-01-08
NCT01875783 OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits https://ClinicalTrials.gov/show/NCT01875783 Completed Joslin Diabetes Center 2015-05-14
NCT01872611 Nepafenac Once Daily for Macular Edema - Study 2 https://ClinicalTrials.gov/show/NCT01872611 Completed Alcon Research 2015-05-31
NCT01869933 Phase I Study Assessing the Ocular and Systemic Safety and Tolerability of OC-10X https://ClinicalTrials.gov/show/NCT01869933 Completed OcuCure Therapeutics, Inc. 2013-06-30
NCT01854593 Prospective Randomized Controlled Study of Intravitreal Injection of Bevacizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01854593 Completed Nihon University 2013-08-31
NCT01837121 a Trial of Using SMS Reminder Among Diabetic Retinopathy Patients in Rural China https://ClinicalTrials.gov/show/NCT01837121 Completed Sun Yat-sen University 2017-06-30
NCT01813773 Treatment With Intravitreal Aflibercept Injection For Proliferative Diabetic Retinopathy, The A.C.T Study https://ClinicalTrials.gov/show/NCT01813773 Completed Ophthalmic Consultants of Long Island 2016-04-30
NCT01805297 Aflibercept Injection for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01805297 Completed University of Oklahoma 2014-02-28
NCT01787669 Trial of Switching Between Intravitreal Bevacizumab (Avastin®)& Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT01787669 Completed University of Sydney 2017-01-31
NCT01769183 Squalamine for the Treatment in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01769183 Completed Elman Retina Group 2014-08-31
NCT01766362 Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients. https://ClinicalTrials.gov/show/NCT01766362 Completed Centre Hospitalier Universitaire Dijon 2015-11-30
NCT01758757 Comparison of Small-gauge Vitrectomy and Conventional Vitrectomy for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01758757 Completed Kyorin University 2011-01-31
NCT01746563 Intravitreal Ranibizumab Combined With Panretinal Photocoagulation in Patients With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01746563 Completed University of Sao Paulo 2012-08-31
NCT01744132 Overcoming Barriers in Vision Care Utilization of African Americans With Diabetes https://ClinicalTrials.gov/show/NCT01744132 Completed Wills Eye 2016-10-31
NCT01743781 Uptake of Comprehensive Eye Examination Trial https://ClinicalTrials.gov/show/NCT01743781 Completed Sun Yat-sen University 2013-09-30
NCT01736059 Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy https://ClinicalTrials.gov/show/NCT01736059 Enrolling by invitation University of California, Davis 2022-01-31
NCT01726075 Trial to Assess the Efficacy of Neuroprotective Drugs Administered Topically to Prevent or Arrest Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01726075 Completed BCN Peptides 2015-11-30
NCT01724554 Impact of Intravitreal Aflibercept Injections on Capillary Non-Perfusion https://ClinicalTrials.gov/show/NCT01724554 Completed Ophthalmic Consultants of Boston 2014-10-31
NCT01724385 Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01724385 Completed Khon Kaen University 2012-12-31
NCT01694212 Preoperative Topic Diclofenac as a Prevention of Postoperative Macular Edema in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01694212 Completed Eye Clinic Medic Zuljan Jukic 2016-10-31
NCT01646047 Diabetes Visual Function Supplement Study https://ClinicalTrials.gov/show/NCT01646047 Completed ZeaVision, LLC 2014-08-31
NCT01628289 The Cost-effectiveness of Screening for Diabetic Retinopathy in Hong Kong https://ClinicalTrials.gov/show/NCT01628289 Completed The University of Hong Kong 2009-08-31
NCT01627977 Association of Lutein, Zeaxanthin and Brilliant Blue in Chromovitrectomy https://ClinicalTrials.gov/show/NCT01627977 Completed Federal University of São Paulo 2014-01-31
NCT01594281 Multicenter 12 Months Clinical Study to Evaluate Efficacy and Safety of Ranibizumab Alone or in Combination With Laser Photocoagulation vs. Laser Photocoagulation Alone in Proliferative Diabetic Retinopathy (PRIDE) https://ClinicalTrials.gov/show/NCT01594281 Completed Novartis 2016-11-30
NCT01571232 Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01571232 Completed Retina Macula Institute 2014-02-28
NCT01535495 Propranolol for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01535495 Completed University of Wisconsin, Madison 2015-12-31
NCT01506895 A Phase 2 Clinical Study to Investigate Effects of Darapladib in Subjects With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01506895 Completed GlaxoSmithKline 2013-02-28
NCT01504724 Effect of the Adjunctive IVB Before PRP https://ClinicalTrials.gov/show/NCT01504724 Completed Kyungpook National University Hospital 2012-08-31
NCT01489189 Prompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01489189 Completed Jaeb Center for Health Research 2015-01-31
NCT01487070 A Single-Center Trial of Intravitreous Injections of Macugen (Pegaptanib Sodium) Given at Least 7 Days Before Vitrectomy Secondary To Tractional Retinal Detachment in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01487070 Completed Retina Institute of Hawaii 2011-07-31
NCT01476449 Dosing Study of Ranibizumab for Diabetic Retinal and Macular Edema https://ClinicalTrials.gov/show/NCT01476449 Completed Retina Vitreous Associates of Florida 2016-09-30
NCT01445899 PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01445899 Completed Quark Pharmaceuticals 2013-11-30
NCT01383772 Retinal Laser by Multi-spot Photocoagulator and Driving Eligibility https://ClinicalTrials.gov/show/NCT01383772 Completed Moorfields Eye Hospital NHS Foundation Trust 2014-08-31
NCT01373476 Multicentre, Randomized, Controlled Trial of Qideng Mingmu Capsule in The Treatment of Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01373476 Completed Chengdu University of Traditional Chinese Medicine 2013-03-31
NCT01364129 The Comparative Effectiveness of Telemedicine to Detect Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01364129 Completed Legacy Health System 2011-12-31
NCT01323348 Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes Control https://ClinicalTrials.gov/show/NCT01323348 Completed Jaeb Center for Health Research 2014-07-31
NCT01320345 The Fenofibrate And Microvascular Events in Type 1 Diabetes Eye. https://ClinicalTrials.gov/show/NCT01320345 Recruiting University of Sydney 2022-01-31
NCT01319487 Safety and Efficacy Study of Topical Administration of FOV2304 (High Dose or Low Dose) for the Treatment of Center-involving Clinically Significant Macular Edema Associated With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01319487 Completed Fovea Pharmaceuticals SA 2012-03-31
NCT04436900 Evaluation of Macular Structural and Functional Function Following Extensive Retinal Laser Therapy in Patients With Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT04436900 Completed Baqiyatallah Medical Sciences University 2019-02-10
NCT04418427 ADVM-022 Intravitreal Gene Therapy for DME https://ClinicalTrials.gov/show/NCT04418427 Recruiting Adverum Biotechnologies, Inc. 2021-05-31
NCT04380077 Gas Tamponade for Prevention of Postoperative Vitreous Hemorrhage in Diabetics https://ClinicalTrials.gov/show/NCT04380077 Recruiting Rush Eye Associates 2024-06-01
NCT04380064 Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT04380064 Recruiting Rush Eye Associates 2024-06-01
NCT04359771 Transfoveal Micropulse Laser for Center Involving Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04359771 Completed Cairo University 2018-09-25
NCT04285151 Nd:YAG Laser Hyaloidotomy for Premacular Hemorrhage in Diabetic Eyes https://ClinicalTrials.gov/show/NCT04285151 Completed Tanta University 2020-01-31
NCT04271709 Manhattan Vision Screening and Follow-Up Study https://ClinicalTrials.gov/show/NCT04271709 Recruiting Columbia University 2024-09-30
NCT04265261 A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT04265261 Recruiting Hoffmann-La Roche 2022-02-09
NCT04215445 Effect of SGLT2 Inhibition on OCT-A Parameters in Diabetic CKD https://ClinicalTrials.gov/show/NCT04215445 Recruiting National University of Malaysia 2020-05-31
NCT04187443 MS-553 in Diabetic Retinopathy Patients With Central Involved Macular Edema https://ClinicalTrials.gov/show/NCT04187443 Recruiting MingSight Pharmaceuticals Pty Limited 2021-08-18
NCT04141891 Advancing Understanding of Transportation Options https://ClinicalTrials.gov/show/NCT04141891 Recruiting University of Colorado, Denver 2023-08-01
NCT04103671 Pars-plana Vitrectomy vs Panretinal Photocoagulation for Severe NPDR https://ClinicalTrials.gov/show/NCT04103671 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2021-12-31
NCT04071977 Combined Antioxidant Therapy on Oxidative Stress in Aqueous and Vitreous Humor of Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT04071977 Recruiting University of Guadalajara 2021-01-31
NCT04038125 Increase in Capillary Plexus Density Level Following the Use of Ozurdex for the Treatment of DME https://ClinicalTrials.gov/show/NCT04038125 Recruiting Retina Macula Specialists of Miami, LLC 2020-08-31
NCT04018482 Povidone Iodine vs AVEnova: A Pre-injection Disinfection Study (PAVE Study) https://ClinicalTrials.gov/show/NCT04018482 Completed California Retina Consultants 2019-08-14
NCT03973762 A Blinded, Self-control Trial to Evaluate an Artificial Intelligence Based CAD System for Diabetic Retinography https://ClinicalTrials.gov/show/NCT03973762 Recruiting Peking Union Medical College Hospital 2020-08-15
NCT03970161 Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03970161 Recruiting Third Affiliated Hospital, Sun Yat-Sen University 2021-06-01
NCT03962296 A Multicenter, Randomized, Double-blind Non-inferiority Trial to Evaluate the Efficacy and Safety of Entelon® https://ClinicalTrials.gov/show/NCT03962296 Completed Hanyang University 2015-01-26
NCT03956797 Long Term Safety of Cooling Anesthesia for Intravitreal Injection https://ClinicalTrials.gov/show/NCT03956797 Recruiting Recens Medical, Inc. 2020-05-30
NCT03904056 ETDRS PRP With IVR Versus Retinal Photocoagulation Targeted to Ischemic Retina With IVR for the Treatment of PDR https://ClinicalTrials.gov/show/NCT03904056 Completed São Paulo State University 2017-07-01
NCT03902925 Pain During Pars Plana Vitrectomy With Sub-tenon Anesthesia https://ClinicalTrials.gov/show/NCT03902925 Completed University of Sao Paulo 2019-08-31
NCT03901898 Feasibility of an Intervention to Increase Diabetic Retinopathy Screening Attendance https://ClinicalTrials.gov/show/NCT03901898 Active, not recruiting University College Cork 2020-06-30
NCT03863535 PRP vs PRP+IVC for Severe nPDR https://ClinicalTrials.gov/show/NCT03863535 Recruiting Ruijin Hospital 2021-01-01
NCT03859245 Photobiomodulation & Ketogenic Diet for Treatment of Mid-periphery Retinal Disorders for Alzheimer’s Disease Prevention https://ClinicalTrials.gov/show/NCT03859245 Recruiting Bristlecone Health, Inc. 2020-09-30
NCT03828890 Assess Screening for Diabetic Retinopathy Using Retinal Camera in Family Medicine Clinic https://ClinicalTrials.gov/show/NCT03828890 Completed Mayo Clinic 2020-03-15
NCT03765112 Macular Involvement in Diabetic Retinopathy Evaluated With Swept-Source OCT https://ClinicalTrials.gov/show/NCT03765112 Recruiting University of British Columbia 2019-12-31
NCT03755752 Safety of Trypan Blue on Endothelium of Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT03755752 Completed Assiut University 2018-07-25
NCT03702374 Combined Antioxidant Therapy on Oxidative Stress, Mitochondrial Dysfunction Markers in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03702374 Recruiting University of Guadalajara 2021-01-31
NCT03696810 Characterization of Retinal Vascular Disease in Eyes With Mild to Moderate NPDR in Diabetes Type 2 https://ClinicalTrials.gov/show/NCT03696810 Active, not recruiting Association for Innovation and Biomedical Research on Light and Image 2019-12-31
NCT03680794 Soluble Cluster of Differentiation 160 (sCD160) in Sera and Intra-ocular Fluids: Association With Ischaemic Retinopathies https://ClinicalTrials.gov/show/NCT03680794 Recruiting CHU de Reims 2021-12-01
NCT03672656 Pattern Laser Versus Conventional Laser in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03672656 Completed University Hospital Ostrava 2013-12-31
NCT03666923 A Study to Evaluate the Safety of THR-687 in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03666923 Completed Oxurion 2019-11-20
NCT03660384 Silicone Oil Versus Long-acting Gas Tamponade in Proliferative Diabetic Retinopathy Patients With High-grade Vitreoretinal Adhesion Undergoing Vitrectomy https://ClinicalTrials.gov/show/NCT03660384 Recruiting Rush Eye Associates 2020-09-04
NCT03660371 Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging https://ClinicalTrials.gov/show/NCT03660371 Recruiting Rush Eye Associates 2020-09-04
NCT03660345 Pars Plana Vitrectomy With Internal Limiting Membrane Peeling Versus Intravitreal Ziv-Aflibercept for Treatment-Naïve Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03660345 Recruiting Rush Eye Associates 2020-09-04
NCT03531294 Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement https://ClinicalTrials.gov/show/NCT03531294 Active, not recruiting Greater Houston Retina Research 2021-04-30
NCT03511898 A Study to Evaluate the Safety of THR-149 in Subjects With Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT03511898 Completed Oxurion 2019-05-22
NCT03499223 A Study to Evaluate THR-317 and Ranibizumab Combination Treatment for Diabetic Macular Oedema (DME) https://ClinicalTrials.gov/show/NCT03499223 Completed Oxurion 2019-07-18
NCT03478306 Diabetic Retinopathy: Effects of Melatonin Treatment on Visual Functions and Circadian Rhythm https://ClinicalTrials.gov/show/NCT03478306 Recruiting Glostrup University Hospital, Copenhagen 2020-10-01
NCT03453281 Early Anatomical, Physiological, and Clinical Changes in Diabetic Macular Edema After Intravitreal Aflibercept Injection https://ClinicalTrials.gov/show/NCT03453281 Completed Indonesia University 2018-04-09
NCT03439345 Lowering Events in Non-proliferative Retinopathy in Scotland https://ClinicalTrials.gov/show/NCT03439345 Recruiting University of Oxford 2023-08-31
NCT03426540 Intravitreal Conbercept After Vitrectomy https://ClinicalTrials.gov/show/NCT03426540 Completed Tianjin Medical University Eye Hospital 2018-03-30
NCT03422965 Perifoveal Vascular Network Assessed by OCT-Angiography in Type I Diabetes Mellitus https://ClinicalTrials.gov/show/NCT03422965 Recruiting Hospital Clinic of Barcelona 2019-05-08
NCT01257815 Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment https://ClinicalTrials.gov/show/NCT01257815 Completed Novartis 2013-04-30
NCT01255293 Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments https://ClinicalTrials.gov/show/NCT01255293 Completed Mid Atlantic Retina 2012-10-31
NCT01225653 Topical Application of Latanoprost in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01225653 Completed University of Aarhus 2014-12-31
NCT01223612 Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation https://ClinicalTrials.gov/show/NCT01223612 Completed Moorfields Eye Hospital NHS Foundation Trust 2012-07-31
NCT01202461 Triple Therapy of Pars Plana Vitrectomy and Grid/Focal Laser for Diabetic Macular Edema (DME) https://ClinicalTrials.gov/show/NCT01202461 Completed Samsung Medical Center 2010-08-31
NCT01201161 Ranibizumab for Diabetic Traction Retinal Detachment https://ClinicalTrials.gov/show/NCT01201161 Completed University of Sao Paulo 2010-01-31
NCT01189461 Study To Evaluate Safety And Tolerability Of Pegaptanib Sodium In Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01189461 Completed Pfizer 2012-07-31
NCT01179555 Confronting Unequal Eye Care in Pennsylvania https://ClinicalTrials.gov/show/NCT01179555 Completed Wills Eye 2014-05-31
NCT01115257 Severe Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01115257 Completed Universita degli Studi di Catania 2006-10-31
NCT01102946 Panretinal Photocoagulation (PRP) Plus Ranibizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01102946 Completed University of Sao Paulo 2011-02-28
NCT01075347 Topical Autologous Serum Application for the Treatment of Corneal Epithelium Defect After Ocular Surgeries https://ClinicalTrials.gov/show/NCT01075347 Completed National Taiwan University Hospital 2008-03-31
NCT01069341 Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery https://ClinicalTrials.gov/show/NCT01069341 Completed Bhagat, Neelakshi, M.D., M.P.H. 2011-12-31
NCT01041690 Efficacy of PreOperative Bevacizumab for Diabetic Eye Disease https://ClinicalTrials.gov/show/NCT01041690 Completed Cairo University 2008-06-30
NCT01025934 Intravitreal Bevacizumab for Surgical Treatment of Severe Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01025934 Completed University of Campania “Luigi Vanvitelli” NA
NCT01009021 Oral Diclofenac for Retinal Photocoagulation in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01009021 Completed University of Sao Paulo 2009-03-31
NCT00996437 Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy (N) https://ClinicalTrials.gov/show/NCT00996437 Completed Jaeb Center for Health Research 2012-02-29
NCT00970723 High Blood Pressure and Sleep Apnea in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00970723 Completed Assistance Publique - Hôpitaux de Paris 2014-01-31
NCT00917553 Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00917553 Completed Milton S. Hershey Medical Center 2012-07-31
NCT00907114 Topic Ketorolac Added to Panphotocoagulation in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00907114 Completed Hospital Juarez de Mexico 2015-03-31
NCT00904592 A Study on Traditional Chinese Medicine (TCM) Comprehensive Protocol of Prevention and Control in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00904592 Completed Chengdu University of Traditional Chinese Medicine 2010-10-31
NCT00900887 Topic Antiinflammatory Therapy Added to Selective Photocoagulation in Macular Edema https://ClinicalTrials.gov/show/NCT00900887 Completed Hospital Juarez de Mexico 2015-03-31
NCT00864838 Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis for Ocular Hypertension Control After Intravitreal Bevacizumab https://ClinicalTrials.gov/show/NCT00864838 Completed University of Sao Paulo 2009-02-28
NCT04448496 Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema https://ClinicalTrials.gov/show/NCT04448496 Recruiting Yeungnam University College of Medicine 2021-12-31
NCT03752840 Village-Integrated Eye Worker Trial II https://ClinicalTrials.gov/show/NCT03752840 Recruiting Francis I. Proctor Foundation 2023-07-31
NCT00814008 The Relationship Between Stage of Diabetic Retinopathy and Retinal Blood Flow in Patients With IDDM During Euglycemic Clamp https://ClinicalTrials.gov/show/NCT00814008 Completed Medical University of Vienna 2000-04-30
NCT01853072 Nepafenac Once Daily for Macular Edema - Study 1 https://ClinicalTrials.gov/show/NCT01853072 Completed Alcon Research 2015-05-31
NCT00806169 Combined Triple Therapy in Diabetic Retinopathy (DRP) https://ClinicalTrials.gov/show/NCT00806169 Completed Johann Wolfgang Goethe University Hospital 2008-10-31
NCT00804921 Effectiveness of Oral Acetazolamide, Brimonidine Tartarate, and Anterior Chamber Paracentesis in Intraocular Pressure (IOP) After Bevacizumab https://ClinicalTrials.gov/show/NCT00804921 Completed University of Sao Paulo NA
NCT00802269 Pain Using Reduced Fluence Parameters in Photocoagulation for Diabetic Retinopathy. https://ClinicalTrials.gov/show/NCT00802269 Completed Asociación para Evitar la Ceguera en México 2008-11-30
NCT02579837 CLEAR SIGHT: A Trial of Non-Mydriatic Ultra-Widefield Retinal Imaging to Screen for Diabetic Eye Disease https://ClinicalTrials.gov/show/NCT02579837 Active, not recruiting Western University, Canada 2020-07-31
NCT02486484 Ziv-aflibercept in Ocular Disease Requiring Anti-VEGF Injection https://ClinicalTrials.gov/show/NCT02486484 Recruiting Rafic Hariri University Hospital 2019-05-31
NCT04009980 Long-term Retinal Changes After Topical Citicoline Administration in Patients With Mild Signs of Diabetic Retinopathy in Type 1 Diabetes Mellitus. https://ClinicalTrials.gov/show/NCT04009980 Completed Fondazione G.B. Bietti, IRCCS 2018-10-31
NCT00782717 A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT00782717 Completed Alcon Research 2010-07-31
NCT00776763 Ocular Growth Factors Profile in Proliferative Retinopathies Before and After Intravitreal Bevacizumab https://ClinicalTrials.gov/show/NCT00776763 Completed Ophthalmological Association Edelweiss 2009-10-31
NCT00745498 Pre- and Intra-operative Intravitreal Bevacizumab Injection in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00745498 Completed Seoul National University Bundang Hospital 2010-10-31
NCT00711490 Sirolimus to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00711490 Completed National Institutes of Health Clinical Center (CC) 2011-01-31
NCT00690768 Pars Plana Vitrectomy (PPV) Versus Preoperative Intravitreal Bevacizumab Plus PPV to Treat Diabetic Tractional Retinal Detachment (IBETRA) https://ClinicalTrials.gov/show/NCT00690768 Completed University of Sao Paulo 2008-05-31
NCT00682240 Morphological and Functional Retinal Changes Following Retinal Photocoagulation https://ClinicalTrials.gov/show/NCT00682240 Completed Medical University of Vienna 2014-02-28
NCT00665106 Safety and Tolerability of NOVA63035 “Corticosteroid” in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00665106 Completed Santen SAS 2011-09-30
NCT00656435 Bevacizumab and Long Acting Gas in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00656435 Completed National Taiwan University Hospital 2007-08-31
NCT00619034 Pharmacological Intervention in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00619034 Completed University of Aarhus 2010-12-31
NCT00606138 Ranibizumab for Treatment of Persistent Diabetic Neovascularization Assessed by Wide-Field Imaging https://ClinicalTrials.gov/show/NCT00606138 Completed Rush University Medical Center 2010-10-31
NCT00604383 Protein Kinase C (PKC) Inhibitor-Diabetic Retinopathy Phase 3 Study https://ClinicalTrials.gov/show/NCT00604383 Completed Chromaderm, Inc. 2005-06-30
NCT00600262 Intravitreal Bevacizumab for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00600262 Completed Asociación para Evitar la Ceguera en México NA
NCT00600236 HLA and it Relation With the Development of Proliferative Diabetic Retinopathy in Mexican Population https://ClinicalTrials.gov/show/NCT00600236 Completed Asociación para Evitar la Ceguera en México 2008-01-31
NCT00596297 Preoperative Bevacizumab for Vitreous Hemorrhage https://ClinicalTrials.gov/show/NCT00596297 Completed University of Sao Paulo 2008-09-30
NCT00594152 Anti-Nephropathic Effects of Chronic Intermittent Intravenous Insulin Therapy (CIIIT) https://ClinicalTrials.gov/show/NCT00594152 Completed Joslin Diabetes Center NA
NCT00548197 Preoperative Injection of Bevacizumab Prior to Vitreoretinal Surgery in Diabetic Tractional Retinal Detachment https://ClinicalTrials.gov/show/NCT00548197 Completed Iran University of Medical Sciences 2008-02-29
NCT00545870 Bevacizumab Versus Ranibizumab for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00545870 Completed Medical University of Vienna 2013-03-31
NCT00542178 Evaluating How the Treatments in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Study Affect Diabetic Retinopathy (The ACCORD Eye Study) https://ClinicalTrials.gov/show/NCT00542178 Completed National Heart, Lung, and Blood Institute (NHLBI) 2009-12-31
NCT00529594 Analgesic Effect of Etoricoxib (ARCOXIA®) 120MG During Retinal Laser Photocoagulation https://ClinicalTrials.gov/show/NCT00529594 Completed University of Sao Paulo NA
NCT00511875 Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00511875 Completed Milton S. Hershey Medical Center 2012-05-31
NCT00500097 Diabetic Retinopathy and Diabetic Macular Edema Screening by Non-Physicians With Limited Training https://ClinicalTrials.gov/show/NCT00500097 Completed Ministry of Health, Thailand NA
NCT00496405 Unilateral Bevacizumab for Bilateral Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00496405 Completed Asociación para Evitar la Ceguera en México NA
NCT00446381 Effect of Macugen(Pegaptanib)on Surgical Outcomes and VEGF Levels in Diabetic Patients With PDR (Diabetic Retinopathy or CSDME (Macular Edema) https://ClinicalTrials.gov/show/NCT00446381 Completed Lawson Health Research Institute 2008-09-30
NCT00445003 Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00445003 Completed Jaeb Center for Health Research 2009-10-31
NCT00444600 Laser-Ranibizumab-Triamcinolone for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00444600 Completed Jaeb Center for Health Research 2009-12-31
NCT00443521 Triamcinolone as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00443521 Completed University of Sao Paulo NA
NCT00799695 Diabetic Retina Exam Rate Does Not Increase With Phone Reminders in Non-HMO Population https://ClinicalTrials.gov/show/NCT00799695 Completed Henry Ford Health System 2008-05-31
NCT00423059 Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00423059 Completed Yonsei University NA
NCT00414999 A Phase 1 Safety Study of TG100801 Eye Drops in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00414999 Completed TargeGen NA
NCT00411970 20- Versus 23- Gauge System for Pars Plana Vitrectomy https://ClinicalTrials.gov/show/NCT00411970 Completed The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery NA
NCT00411333 Vascular Remodeling and the Effects of Angiogenic Inhibition in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00411333 Completed National Eye Institute (NEI) 2009-07-31
NCT00406991 Retinal Blood Flow and Microthrombi in Type 1 Diabetes https://ClinicalTrials.gov/show/NCT00406991 Completed Massachusetts Eye and Ear Infirmary NA
NCT00401115 Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00401115 Completed Santen Inc. 2008-06-30
NCT00387582 Efficacy Study of Lucentis in the Treatment of Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00387582 Completed Rocky Mountain Retina Consultants 2009-02-28
NCT00385333 Metabolic Mapping to Measure Retinal Metabolism https://ClinicalTrials.gov/show/NCT00385333 Completed National Institutes of Health Clinical Center (CC) 2008-06-01
NCT00355680 Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00355680 Completed Aurolab 2006-07-31
NCT00337298 The Effect of Amlodipine and Lisinopril on Retinal Autoregulation in Type 1 Diabetes https://ClinicalTrials.gov/show/NCT00337298 Completed University of Aarhus 2009-02-28
NCT00336323 A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin) https://ClinicalTrials.gov/show/NCT00336323 Completed Jaeb Center for Health Research 2006-11-30
NCT00295828 A Pilot Study for the Treatment of Iris Neovascularization With Macugen https://ClinicalTrials.gov/show/NCT00295828 Completed Hermann Eye Center 2008-09-30
NCT00266695 Treatment for Completers of the Study B7A-MC-MBCM https://ClinicalTrials.gov/show/NCT00266695 Completed Chromaderm, Inc. 2008-08-31
NCT00252733 Diabetic Retinopathy Candesartan Trials https://ClinicalTrials.gov/show/NCT00252733 Completed AstraZeneca 2008-04-30
NCT00252720 DIabetic Retinopathy Candesartan Trials. https://ClinicalTrials.gov/show/NCT00252720 Completed AstraZeneca 2008-02-29
NCT00252694 DIabetic Retinopathy Candesartan Trials https://ClinicalTrials.gov/show/NCT00252694 Completed AstraZeneca 2008-02-29
NCT00231023 Triamcinolone Acetonide Injections to Treat Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00231023 Completed National Institutes of Health Clinical Center (CC) NA
NCT00198510 Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage https://ClinicalTrials.gov/show/NCT00198510 Completed Bausch & Lomb Incorporated 2001-09-30
NCT00198497 Safety and Efficacy Study of Vitrase for Clearance of Severe Vitreous Hemorrhage https://ClinicalTrials.gov/show/NCT00198497 Completed Bausch & Lomb Incorporated 2001-09-30
NCT00198471 Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment https://ClinicalTrials.gov/show/NCT00198471 Completed Bausch & Lomb Incorporated 2006-11-30
NCT00174824 Comparison of Insulin Glargine and NPH Human Insulin in Progression of Diabetic Retinopathy in Type 2 Diabetic Patients https://ClinicalTrials.gov/show/NCT00174824 Completed Sanofi 2007-04-30
NCT00155454 Intravitreal Long Acting Gas in the Prevention of Early Postoperative Vitreous Hemorrhage in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00155454 Completed National Taiwan University Hospital 2012-12-31
NCT00131144 Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00131144 Completed Novartis 2005-12-31
NCT00130845 Octreotide Acetate in Microspheres in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00130845 Completed Novartis 2005-12-31
NCT00119535 Study to Evaluate the Effectiveness of a Program Developed to Improve Eye Care for Veterans With Diabetes https://ClinicalTrials.gov/show/NCT00119535 Completed VA Office of Research and Development NA
NCT00105404 Treatment of Diabetic Macular Edema: Triamcinolone Injections Vs. Laser Photocoagulation https://ClinicalTrials.gov/show/NCT00105404 Completed National Institutes of Health Clinical Center (CC) NA
NCT00101764 Intravitreal v. Sub-tenon Injections of Triamcinolone Acetonide for Macular Edema in Retinal Disorders https://ClinicalTrials.gov/show/NCT00101764 Completed National Institutes of Health Clinical Center (CC) NA
NCT00090519 Reduction in the Occurrence of Center-Involved Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00090519 Completed Chromaderm, Inc. 2010-04-30
NCT00069056 Pilot Study of Laser Photocoagulation Therapy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00069056 Completed National Institutes of Health Clinical Center (CC) NA
NCT00035906 Research Study in Patients With Persistent Macular Edema https://ClinicalTrials.gov/show/NCT00035906 Completed Allergan 2004-08-31
NCT00000160 Diabetic Retinopathy Study (DRS) https://ClinicalTrials.gov/show/NCT00000160 Completed National Eye Institute (NEI) NA
NCT00000159 Sorbinil Retinopathy Trial (SRT) https://ClinicalTrials.gov/show/NCT00000159 Completed National Eye Institute (NEI) NA
NCT00000154 Diabetic Retinopathy Vitrectomy Study (DRVS) https://ClinicalTrials.gov/show/NCT00000154 Completed National Eye Institute (NEI) NA
NCT00000153 Krypton-Argon Regression of Neovascularization Study (KARNS) https://ClinicalTrials.gov/show/NCT00000153 Completed National Eye Institute (NEI) NA
NCT00000151 Early Treatment Diabetic Retinopathy Study (ETDRS) https://ClinicalTrials.gov/show/NCT00000151 Completed National Eye Institute (NEI) NA

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03713268 Intraoperative OCT Guidance of Intraocular Surgery II https://ClinicalTrials.gov/show/NCT03713268 Recruiting Duke University 2023-05-31
NCT03374020 Retinal Imaging Using NOTAL-OCT https://ClinicalTrials.gov/show/NCT03374020 Active, not recruiting Notal Vision Ltd 2019-12-30
NCT03823092 Polarization Perception in Health and Disease. Testing a New Sight Test https://ClinicalTrials.gov/show/NCT03823092 Recruiting South Warwickshire NHS Foundation Trust 2019-04-30
NCT03821753 The Effect of the Glycemic Variability on Macular Retinal Microcirculation and Cognitive Functions in Patient With Type 1 Diabetes https://ClinicalTrials.gov/show/NCT03821753 Recruiting Assistance Publique - Hôpitaux de Paris 2020-05-01
NCT03314467 Role of Obstructive Sleep Apnea Syndrome in the Occurrence of Diabetic Retinopathy in Type 2 Diabetes. https://ClinicalTrials.gov/show/NCT03314467 Recruiting Centre Hospitalier Universitaire Saint Pierre 2020-06-30
NCT02464800 Efficacy of Higher Cutting Rate in Microincision Vitrectomy for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02464800 Completed Kyorin University 2014-03-31
NCT03135327 Clinical Applications of Advanced Ophthalmic Imaging https://ClinicalTrials.gov/show/NCT03135327 Recruiting University of Miami 2020-12-31
NCT03112005 Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool https://ClinicalTrials.gov/show/NCT03112005 Completed Eyenuk, Inc. 2018-05-31
NCT03078231 Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool https://ClinicalTrials.gov/show/NCT03078231 Completed Eyenuk, Inc. 2017-04-24
NCT03076697 Smartphone Screening for Eye Diseases https://ClinicalTrials.gov/show/NCT03076697 Enrolling by invitation University of Michigan 2023-06-30
NCT03030729 Macular Thickness Measurements Using Retinal-thickness OCT https://ClinicalTrials.gov/show/NCT03030729 Completed Notal Vision Ltd 2018-01-14
NCT02963441 A Multi-center Study to Evaluate Performance of an Automated Device for the Detection of Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02963441 Completed IDx LLC 2017-11-30
NCT02927561 Automated Diagnostic Test for Diabetic Retinopathy in Brazilian Mass Screening https://ClinicalTrials.gov/show/NCT02927561 Completed Retina Clinic, Sao Paulo, Brazil 2016-06-30
NCT02924311 Routine Clinical Practice for Use of Intravitreal Aflibercept Treatment in Patients With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02924311 Completed Bayer 2019-08-12
NCT02876744 Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes https://ClinicalTrials.gov/show/NCT02876744 Active, not recruiting Fondation Ophtalmologique Adolphe de Rothschild 2020-04-13
NCT02876393 A Systematic Study of Retinal Structure and Function in Diabetic Macular Oedema https://ClinicalTrials.gov/show/NCT02876393 Completed Queen’s University, Belfast 2017-01-31
NCT02875704 Oxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02875704 Recruiting Johns Hopkins University 2021-05-31
NCT02691312 Pediatric Type 1 Diabetes and Retinopathy https://ClinicalTrials.gov/show/NCT02691312 Completed University of Florida 2018-01-20
NCT02662010 The Relationship Between Advanced Glycation Endproducts and Diabetes https://ClinicalTrials.gov/show/NCT02662010 Recruiting University of Colorado, Denver 2021-01-31
NCT02639507 International Consortium Investigating Early Vitrectomy in Diabetic Macular Edema Patients https://ClinicalTrials.gov/show/NCT02639507 Completed Mayo Clinic 2020-03-31
NCT02625649 Effect of Gastric Bypass Surgery on Diabetes Status and Microvascular Complications in Obese Type 2 Diabetic Patients https://ClinicalTrials.gov/show/NCT02625649 Completed University of Aarhus 2016-12-31
NCT03403699 Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03403699 Recruiting University of Alabama at Birmingham 2021-01-31
NCT03403686 Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR) https://ClinicalTrials.gov/show/NCT03403686 Recruiting University of Alabama at Birmingham 2021-12-31
NCT03403283 Dyslipidemia and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03403283 Recruiting University of Alabama at Birmingham 2021-12-31
NCT01496625 National Eye Institute Biorepository for Retinal Diseases https://ClinicalTrials.gov/show/NCT01496625 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02391558 Clinical Evaluation of Noninvasive OCT Angiography Using a Zeiss OCT Prototype to Compare to Fluorescein Angiography https://ClinicalTrials.gov/show/NCT02391558 Completed Association for Innovation and Biomedical Research on Light and Image 2016-04-30
NCT02334137 A Pilot Project to Assess the Impact of Diabetes Education During Ophthalmology Visits https://ClinicalTrials.gov/show/NCT02334137 Completed California Pacific Medical Center Research Institute 2015-06-30
NCT02330042 OCT Biomarkers for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02330042 Recruiting Oregon Health and Science University 2021-12-31
NCT02311504 Eye Screening in German Secondary Diabetes Care Centers https://ClinicalTrials.gov/show/NCT02311504 Completed University Hospital Tuebingen 2015-06-30
NCT02232503 Prevalence of DIAbetic RETinopathy and Impact of Genetic Factors in the Development of Diabetic Retinopathy of Patients With Type 1 and 2 Diabetes Mellitus in SlovaKia https://ClinicalTrials.gov/show/NCT02232503 Completed Novartis 2015-11-30
NCT02217306 Contrast Sensitivity and Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT02217306 Completed Hospital Juarez de Mexico 2014-07-31
NCT02126423 Resistance to Antibiotics in Patients Receiving Eye Injections https://ClinicalTrials.gov/show/NCT02126423 Completed Prism Vision Group 2014-09-30
NCT02026843 Analysis of Angiogenic Factor Levels in Eyes With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT02026843 Recruiting Kyungpook National University Hospital 2020-04-30
NCT02077127 Monocyte Chemoattractant Protein-1 2518A/G Polymorphism https://ClinicalTrials.gov/show/NCT02077127 Completed Harbin Medical University 2013-02-28
NCT01307072 Compliance to Ophthalmic Follow-up Examinations and Surgical Outcome for Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01307072 Completed Kyorin University 2009-08-31
NCT01946997 Evaluation of the Retina of Subjects Without Diabetes Mellitus and Subjects With Diabetes Mellitus Without Diabetic Retinopathy Using Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT01946997 Completed Johns Hopkins University 2009-11-30
NCT01928550 Diabetes PRP and OCT https://ClinicalTrials.gov/show/NCT01928550 Completed Oregon Health and Science University 2016-05-25
NCT01871207 Serum and Intraocular Levels of Erythropoietin and VEGF in Type 2 Diabetes Patients With Proliferative Retinopathy https://ClinicalTrials.gov/show/NCT01871207 Completed Università degli Studi di Brescia 2012-01-31
NCT01760746 Comparison of Changes of Inflammatory Proteins in Aqueous Humour of Subjects Treated With Avastin vs Lucentis https://ClinicalTrials.gov/show/NCT01760746 Completed University of British Columbia 2013-10-31
NCT01728883 Diabetic Retinopathy And the Myvisiontrack® (DRAMA) Study https://ClinicalTrials.gov/show/NCT01728883 Completed Vital Art and Science Incorporated 2016-04-30
NCT01692938 Evaluation of the Precision of the Microperimetry Function of the Spectral OCT/SLO https://ClinicalTrials.gov/show/NCT01692938 Completed Optos, PLC 2012-11-30
NCT01625598 Computer Detection of Diabetic Retinopathy Compared to Clinical Examination https://ClinicalTrials.gov/show/NCT01625598 Completed IDx LLC 2014-04-30
NCT01622816 Comparing Visual Acuity Measurements (How Well You Can See) Using a Standard ETDRS Chart & a Handheld ETDRS Chart https://ClinicalTrials.gov/show/NCT01622816 Completed Wills Eye 2013-12-31
NCT01614327 Computer-based Screening for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01614327 Completed VisionQuest Biomedical LLC 2015-02-24
NCT01607190 Biomarkers of Diabetic Retinopathy Progression https://ClinicalTrials.gov/show/NCT01607190 Completed Association for Innovation and Biomedical Research on Light and Image 2016-04-30
NCT01546766 Rapid, Non-invasive, Regional Functional Imaging of the Retina. (Diabetic Retinopathy Diagnosis Device) https://ClinicalTrials.gov/show/NCT01546766 Completed University of California, Los Angeles 2015-08-31
NCT01478763 Vitrous Analysis in Proliferative Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01478763 Completed St. Erik Eye Hospital 2014-09-30
NCT01440660 Phenotypes of Nonproliferative Diabetic Retinopathy in DM 2 Patients Identified by OCT, CFP, RLA and mfERG (DIAMARKER) https://ClinicalTrials.gov/show/NCT01440660 Completed Association for Innovation and Biomedical Research on Light and Image 2014-09-30
NCT01415037 Annular Array Ultrasound in Ophthalmology https://ClinicalTrials.gov/show/NCT01415037 Completed Columbia University 2016-12-31
NCT04378972 Anti-inflammatory Effect of Curcumin, Homotaurine, Vitamin D3 on Human Vitreous in Patients With Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT04378972 Completed University of Molise 2019-11-16
NCT04302012 Assessment of EyeArt Performance With Retinal Imaging Devices https://ClinicalTrials.gov/show/NCT04302012 Enrolling by invitation Eyenuk, Inc. 2020-02-28
NCT04101604 Biomarkers of Common Eye Diseases https://ClinicalTrials.gov/show/NCT04101604 Recruiting Sun Yat-sen University 2020-10-01
NCT04018833 Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT04018833 Completed Centro Hospitalar do Porto 2016-06-01
NCT04018326 Loss to Follow-up in PDR Patients https://ClinicalTrials.gov/show/NCT04018326 Completed Assiut University 2018-06-01
NCT03922932 WF and PR OCTA in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03922932 Recruiting Oregon Health and Science University 2023-12-31
NCT03912961 The Santa Cruz Diabetic Retinopathy Utilizing Artificial Intelligence Study https://ClinicalTrials.gov/show/NCT03912961 Completed Retina Global 2019-04-14
NCT03911323 Real-world Diagnostic Effectiveness of Artificial Intelligence Algorithm in Diabetic Retinopathy Screening https://ClinicalTrials.gov/show/NCT03911323 Recruiting Shenzhen Second People’s Hospital 2020-10-01
NCT03903042 Comparison of Aurora Fundus Camera With Traditional Camera in Diabetic Retinopathy With Visual Artificial Intelligence https://ClinicalTrials.gov/show/NCT03903042 Enrolling by invitation Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 2019-05-31
NCT03899623 Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application https://ClinicalTrials.gov/show/NCT03899623 Recruiting Zhongshan Ophthalmic Center, Sun Yat-sen University 2019-12-31
NCT03843840 Dual Wavelength OCT https://ClinicalTrials.gov/show/NCT03843840 Recruiting Moorfields Eye Hospital NHS Foundation Trust 2019-07-31
NCT03665090 Shanghai Cohort Study of Diabetic Eye Disease https://ClinicalTrials.gov/show/NCT03665090 Enrolling by invitation Shanghai Eye Disease Prevention and Treatment Center 2018-12-31
NCT03609996 Retrospective Review of Proliferative Diabetic Retinopathy Patients https://ClinicalTrials.gov/show/NCT03609996 Active, not recruiting Elman Retina Group 2018-12-01
NCT03602989 A Multi-center Study on the Artificial Intelligence Enabled Diabetic Retinopathy Screening Based on Fundus Images https://ClinicalTrials.gov/show/NCT03602989 Active, not recruiting Shenzhen SiBright Co., Ltd. 2018-11-30
NCT03597815 Diabetic Macular Edema - Obstructive Sleep Apnea Relationship Study https://ClinicalTrials.gov/show/NCT03597815 Active, not recruiting Uptown Eye Specialists 2018-12-31
NCT03594591 Changes in the Retinal and Carotid Microcirculation After Restoring Normoglycemia in Patients With Type 2 Diabetes https://ClinicalTrials.gov/show/NCT03594591 Recruiting Hospital Clinic of Barcelona 2020-01-01
NCT03572699 Simple, Mobile-based Artificial Intelligence AlgoRithms in the Detection of Diabetic ReTinopathy (SMART) Study https://ClinicalTrials.gov/show/NCT03572699 Recruiting Medios Technologies Pte. Ltd 2018-10-31
NCT03571659 Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT03571659 Completed L.V. Prasad Eye Institute 2014-12-22
NCT03528720 Evaluation System and Clinical Application for Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT03528720 Completed Guangdong Provincial People’s Hospital 2018-04-30
NCT03525899 Macular Hole After Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT03525899 Completed National Taiwan University Hospital 2017-12-01
NCT03522311 Surgical Outcomes for Proliferative Diabetic Retinopathy by Preoperative Glycemic Control and Renal Function https://ClinicalTrials.gov/show/NCT03522311 Completed Kyorin University 2016-03-31
NCT03437551 Prevalence of DRP and DME Among Type 1 Diabetics Treated With Long-term Intensified Insulin Therapy https://ClinicalTrials.gov/show/NCT03437551 Completed Vista Klinik 2014-12-31
NCT01228981 Observational Study to Assess Genotypes/Phenotypes Correlations in Type-2 Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT01228981 Completed Association for Innovation and Biomedical Research on Light and Image 2011-06-30
NCT01220804 Evaluation of Blood-retinal Barrier Functional Alterations by Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT01220804 Completed Association for Innovation and Biomedical Research on Light and Image 2011-12-31
NCT01145599 Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures https://ClinicalTrials.gov/show/NCT01145599 Completed European Vision Institute Clinical Research Network 2013-10-31
NCT01131650 Prevalence of Diabetic Retinopathy in São José do Rio Preto-SP-Brazil https://ClinicalTrials.gov/show/NCT01131650 Completed Hospital do Olho Rio Preto 2009-11-30
NCT00906659 Visual Function, Center Point Thickness and Macular Volume After Photocoagulation https://ClinicalTrials.gov/show/NCT00906659 Completed Hospital Juarez de Mexico 2007-12-31
NCT00886392 Diabetic Macular Edema Severity at Diagnosis https://ClinicalTrials.gov/show/NCT00886392 Completed Hospital Juarez de Mexico 2007-12-31
NCT00840541 Phenotyping Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00840541 Completed Association for Innovation and Biomedical Research on Light and Image 2010-01-31
NCT03437018 MONITORING OF MODERATE DIABETIC RETINOPATHY BY TELE-EXPERTISE https://ClinicalTrials.gov/show/NCT03437018 Recruiting Centre Hospitalier Sud Francilien 2021-01-13
NCT03345667 Assessment of Color Vision in Diabetic Patients https://ClinicalTrials.gov/show/NCT03345667 Completed Instituto de Olhos de Goiania 2017-10-01
NCT04025996 REWARD: Using the REtina as a Window To Detect Cardiac microvasculAR Dysfunction In Diabetes Mellitus https://ClinicalTrials.gov/show/NCT04025996 Recruiting National Heart Centre Singapore 2020-03-31
NCT02637245 Imaging Parameters and DME Treatment Response https://ClinicalTrials.gov/show/NCT02637245 Recruiting Duke University 2020-05-31
NCT04030611 The Sensitivity of Traditional Chinese Medical Diagnostic Tools for Diabetic Retinopathy Diabetic retinopathy-a Pilot Study https://ClinicalTrials.gov/show/NCT04030611 Recruiting China Medical University Hospital 2019-09-01
NCT03694145 Predicting Diabetic Retinopathy From Risk Factor Data and Digital Retinal Images https://ClinicalTrials.gov/show/NCT03694145 Recruiting Charles Drew University of Medicine and Science 2020-09-30
NCT00763802 Validation of a Predictive Model to Estimate the Risk of Conversion to Clinically Significant Macular Edema and/or Vision Loss in Mild Nonproliferative Diabetic Retinopathy in Diabetes Type 2 https://ClinicalTrials.gov/show/NCT00763802 Completed Association for Innovation and Biomedical Research on Light and Image 2010-09-30
NCT00737074 Macular Hole in Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00737074 Completed National Taiwan University Hospital 2007-11-30
NCT00737022 Macular Appearance After Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00737022 Completed National Taiwan University Hospital 2006-07-31
NCT00728598 Fractalkine, a CX3C Chemokine, Act as a Mediator of Ocular Angiogenesis https://ClinicalTrials.gov/show/NCT00728598 Completed National Taiwan University Hospital 1998-12-31
NCT00720317 Diabetic Retinopathy and Sickle Trait https://ClinicalTrials.gov/show/NCT00720317 Completed Medical University of South Carolina 2010-07-31
NCT00712842 Neurovascular Coupling in Patients With Early Stage Diabetes Retinopathy https://ClinicalTrials.gov/show/NCT00712842 Completed Medical University of Vienna 2011-09-30
NCT00709319 Evaluation of Vitrectomy for Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT00709319 Completed Jaeb Center for Health Research 2008-08-31
NCT00647439 Genetics and Markers of Degenerative and Inflammatory Eye Diseases https://ClinicalTrials.gov/show/NCT00647439 Completed National Institutes of Health Clinical Center (CC) NA
NCT00596505 Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy https://ClinicalTrials.gov/show/NCT00596505 Completed National Taiwan University Hospital 2007-12-31
NCT00556114 A Pilot Study of Functional Optical Coherence Tomography for Ocular Imaging https://ClinicalTrials.gov/show/NCT00556114 Completed University of California, Irvine 2013-07-31
NCT00442156 The Course of Response to Focal Photocoagulation for DME https://ClinicalTrials.gov/show/NCT00442156 Completed Jaeb Center for Health Research 2008-06-30
NCT00403195 Clinical and Pathophysiological Description of Ocular Ischemic Syndrome https://ClinicalTrials.gov/show/NCT00403195 Completed Glostrup University Hospital, Copenhagen 2009-01-31
NCT00343603 Tracking Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT00343603 Completed University of Pittsburgh 2010-12-31
NCT00797524 Function and Structure Imaging in Different Retinal Diseases: Retinal Leakage Analyzer Versus Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT00797524 Completed Association for Innovation and Biomedical Research on Light and Image 2010-10-31
NCT00797134 Retinal Thickness Analysis Using Optical Coherence Tomography https://ClinicalTrials.gov/show/NCT00797134 Completed Association for Innovation and Biomedical Research on Light and Image 2010-07-31
NCT00001612 Long-Term Follow-Up of Patients Enrolled in the Early Treatment Diabetic Retinopathy Study (ETDRS) https://ClinicalTrials.gov/show/NCT00001612 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001395 Long Term Follow-Up of Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00001395 Completed National Institutes of Health Clinical Center (CC) NA
NCT00001346 Diabetic Retinopathy and Visual Function Study https://ClinicalTrials.gov/show/NCT00001346 Completed National Institutes of Health Clinical Center (CC) NA
NCT00041444 Multi-Ethnic Study of Atherosclerosis (MESA) - Ancillary Eye Study https://ClinicalTrials.gov/show/NCT00041444 Completed University of Wisconsin, Madison 2006-11-30
NCT00001733 Screening for Studies on Retinovascular Diseases https://ClinicalTrials.gov/show/NCT00001733 Completed National Institutes of Health Clinical Center (CC) NA
NCT00005761 Blood Factors and Diabetic Retinopathy https://ClinicalTrials.gov/show/NCT00005761 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03010397 Progression of Diabetic Retinopathy. Identification of Signs and Surrogate Outcomes https://ClinicalTrials.gov/show/NCT03010397 Completed Association for Innovation and Biomedical Research on Light and Image 2017-01-11
NCT02119689 Vascular Reparative Mechanism in Diabetes https://ClinicalTrials.gov/show/NCT02119689 Active, not recruiting University of Alabama at Birmingham 2019-10-09
NCT01824862 Reduction of Foveal Sensitivity in Eyes With Diabetic Macular Edema https://ClinicalTrials.gov/show/NCT01824862 Completed Hospital Juarez de Mexico 2013-06-30
NCT01785667 Incidence of Retinopathy and Associated Risk Factors in Children and Young Adults With Type 1 Diabetes in Denmark https://ClinicalTrials.gov/show/NCT01785667 Completed Odense University Hospital 2011-11-30
NCT04240652 The Diabetic Retinopathy Screening, Prevention and Control Program https://ClinicalTrials.gov/show/NCT04240652 Recruiting Shanghai Jiao Tong University School of Medicine 2038-06-05
NCT04128150 High Resolution Retina Imaging https://ClinicalTrials.gov/show/NCT04128150 Recruiting Centre Hospitalier National d’Ophtalmologie des Quinze-Vingts 2023-01-30
NCT03571217 Shanghai Beixinjing Diabetic Eyes Study https://ClinicalTrials.gov/show/NCT03571217 Recruiting Shanghai Eye Disease Prevention and Treatment Center 2024-12-31
NCT03476967 Effect of Laser Treatment for Diabetic Retinopathy on the Optic Disc Topography https://ClinicalTrials.gov/show/NCT03476967 Completed University of Sao Paulo General Hospital 2017-01-31